Japan

Tokyo stock exchange
Biotech

Cell therapy biotech could end Tokyo IPO drought with $92M offer

Japan-based cell therapy company Innovacell is planning to end a drought of biotech IPOs on the Tokyo Stock Exchange next week.
James Waldron Feb 17, 2026 11:06am
Chugai Matsunage plant circa 1943

JPM26: Chugai chases new science and name recognition

Jan 16, 2026 5:28am
graphic art of a right hand signing something

Hansoh, Chugai ink separate and lucrative licensing agreements

Oct 17, 2025 11:04am
A ballpoint pen rests on top of a stack of documents ready for signing

Kyorin pens $105M pact for Japan rights to Hinge's lupus drug

Oct 1, 2025 6:40am
A close-up view of a jigsaw puzzle with a missing piece

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am
GE Healthcare Building

Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan

Sep 24, 2025 11:30am